• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Gastroenterology

Development of a risk index for colorectal cancer screening

byMoises GallegosandSai Folmsbee
August 11, 2015
in Gastroenterology, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. From a cross sectional study, this derived index can obtain measures to stratify risk for advanced colorectal neoplasia.

Evidence Rating Level: 2 (Good)

Study Rundown: Colorectal cancer screening has been demonstrated to be both beneficial and cost-effective. The U.S. Preventive Services Task Force recommends several tests and approaches to screening, but overall inefficiency in these has led to high costs. This study sought to develop a decision-making index to risk stratify average-risk persons and distinguish those individuals that may be managed with less invasive testing. Using common risk factors, including age, sex, waist circumference, cigarette smoking, and family history, the study authors created a scoring model to categorize patients into very low, low, intermediate, and high risk strata. Using pathology reports and this classification system, the authors calculated that the majority of patients in the very low and low groups with advanced neoplasm could have been identified with sigmoidoscopy, with success likely increased if fecal blood testing was added, sparing the cost and invasiveness of colonoscopy. Strengths to the model include the use of 5 easily obtained screening factors and an even distribution across risk groups that is improved compared to previous models. Limitations include a high percentage of white patients (94%), a lack of comparison between less-invasive approaches, and an inability to distinguish between proximal and distal disease. Overall, this risk index may inform and improve future colorectal screening.

Click to read the study, published today in Annals of Internal Medicine

Relevant Reading: USPSTF Colorectal Cancer Screening

In-Depth [cross-sectional study]: A total of 4500 participants presenting for first screening colonoscopy were enrolled. Two-thirds of the study group were used as a derivation set and the remaining third as the validation group. Ideal formats for risk factors (i.e., cigarette smoking, history, body fat, age and sex) were determined using individual logistics regressions, and a multivariable regression model was created. The model was well-calibrated (p = 0.42) and demonstrated good discrimination (c-statistic = 0.72). A score of 0-13 was calculated as the sum of points given for age (0 if <55, 1 if 55-60, 2 if 60-65, 3 if 65-70, and 4 if >70 years), sex (0 if F, 1 if M), first-degree relative (1 if one or more), smoking history (0 if none, 2 if 0-30, 4 if >30 pack-years), and waist circumference (0 = small, 1 = medium, 2 = large). Risk groups were defined as very low (score 0), low (score 1-3), intermediate (score 4-6), and high (score > 6), and the risk of neoplasia was 1.92%, 4.88%, 9.93% and 24.9% in these strata, respectively. A total of 51/70 (73%; 95%CI 61-83%) of the advanced neoplasms in the derivation set in the very low and low groups, and 21/24 (87.5%; 95%CI 68%-97%) of the advanced neoplasms in the validation very low and low groups, would have been detected on sigmoidoscopy.

Image: CC/Wiki

RELATED REPORTS

Early exposure to allergenic foods may reduce incidence of long-term food allergy

Risk of post-vitrectomy endophthalmitis may have increased during the COVID-19 pandemic

Bosniak classification system differentiates benign renal cysts from cystic carcinoma [Classics Series]

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Previous Post

2 Minute Medicine Rewind August 3 – August 10, 2015

Next Post

Corticosteroids improve outcomes in treatment of community-acquired pneumonia

RelatedReports

Peripregnancy nut consumption may decrease development of nut allergies
Chronic Disease

Early exposure to allergenic foods may reduce incidence of long-term food allergy

July 5, 2022
Masks for personal protection for SARS-CoV-2 infection
Ophthalmology

Risk of post-vitrectomy endophthalmitis may have increased during the COVID-19 pandemic

July 5, 2022
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Radiology Classics

Bosniak classification system differentiates benign renal cysts from cystic carcinoma [Classics Series]

July 5, 2022
Galcanezumab reduces the frequency of episodic cluster headaches
Chronic Disease

Cognitive behavioral therapy efficacious for treatment of comorbid posttraumatic headache and posttraumatic stress disorder symptoms among US veterans

July 4, 2022
Next Post
Corticosteroids improve outcomes in treatment of community-acquired pneumonia

Corticosteroids improve outcomes in treatment of community-acquired pneumonia

Etiology of pediatric bacteremia and empiric treatment time vary

Internet-based intervention on proper handwashing limits spread of respiratory tract infections [PRIMIT trial]

Variation noted across pre- and post-marketing studies for FDA approved devices

Variation noted across pre- and post-marketing studies for FDA approved devices

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early exposure to allergenic foods may reduce incidence of long-term food allergy
  • Risk of post-vitrectomy endophthalmitis may have increased during the COVID-19 pandemic
  • Bosniak classification system differentiates benign renal cysts from cystic carcinoma [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.